Bexion Pharmaceuticals

Bexion Pharmaceuticals company information, Employees & Contact Information

Updated May 2026

Quick answer

Bexion Pharmaceuticals is a Biotechnology company and founded in 2006. It has approximately 27 employees on record. Contact data was last refreshed in May 2026. Find Bexion Pharmaceuticals's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Poised to Deliver Breakthroughs in Oncology and CNS Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The company’s lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company. To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or call (859) 446-7386.
Looking for a particular Bexion Pharmaceuticals employee's phone or email?

Bexion Pharmaceuticals Questions

News

Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350 - PR Newswire

Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350 PR Newswire

Phase 1b/2 Study of BXQ-350 in Metastatic Colorectal Cancer Completes Enrollment - Targeted Oncology

Phase 1b/2 Study of BXQ-350 in Metastatic Colorectal Cancer Completes Enrollment Targeted Oncology

Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025 - PR Newswire

Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025 PR Newswire

Patient No. 1 and the cancer trial here that just might change everything - Cincinnati Enquirer

Patient No. 1 and the cancer trial here that just might change everything Cincinnati Enquirer

Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC - PR Newswire

Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC PR Newswire

Bexion Pharmaceuticals Announces Leadership Additions - PR Newswire

Bexion Pharmaceuticals Announces Leadership Additions PR Newswire

Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer - PR Newswire

Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer PR Newswire

Charles R. Scheper, Chairman of Bexion Pharmaceuticals Board, Named Great Living Cincinnatian - PR Newswire

Charles R. Scheper, Chairman of Bexion Pharmaceuticals Board, Named Great Living Cincinnatian PR Newswire

Bexion Pharmaceuticals, Inc. Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors - PR Newswire

Bexion Pharmaceuticals, Inc. Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors PR Newswire

Top Bexion Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant